OnKure Therapeutics

(NASDAQ) OKUR

Current Price$5.11

Market Cap$69.74M

Since IPO (2024)-73%

5 YearN/A

1 Year+102%

1 Month+35%

OnKure Therapeutics Financials at a Glance

Market Cap

$69.74M

Revenue (TTM)

$0.00

Net Income (TTM)

$59.52M

EPS (TTM)

$-4.40

P/E Ratio

-1.16

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$5.11

Volume

2,988

Open

$5.24

Price

$5.11

Volume

2,988

Open

$5.24

Previous Close

$5.11

Daily Range

$5.10 - $5.25

52-Week Range

$1.70 - $5.36

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$5.11

Volume

2,988

Open

$5.24

Previous Close

$5.11

Daily Range

$5.10 - $5.25

52-Week Range

$1.70 - $5.36

OKUR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About OnKure Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Nicholas A. Saccomano, PhD

Website

onkuretherapeutics.com

Headquarters

Boulder, CO 80301, US

OKUR Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-74%

Return on Capital

-1%

Return on Assets

-96%

Earnings Yield

-86.21%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$69.74M

Shares Outstanding

13.67M

Volume

2.99K

Avg. Volume

291.13K

Financials (TTM)

Gross Profit

$830.00K

Operating Income

$62.95M

EBITDA

$62.12M

Operating Cash Flow

$51.83M

Capital Expenditure

$46.00K

Free Cash Flow

$51.87M

Cash & ST Invst.

$59.05M

Total Debt

$549.00K

OnKure Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$202.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$69.74M

N/A

Market Cap/Employee

$1.52M

N/A

Employees

N/A

Net Income

$13.50M

+61.6%

EBITDA

$15.66M

+49.7%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$58.50M

-46.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$549.00K

+2.4%

Return on Assets

-95.81%

N/A

Return on Invested Capital

-1.12%

N/A

Free Cash Flow

$11.52M

+45.3%

Operating Cash Flow

$11.51M

+45.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

KZRKezar Life Sciences, Inc.

KZRKezar Life Sciences, Inc.$7.30-0.14%

PDSBPDS Biotechnology Corporation

PDSBPDS Biotechnology Corporation$0.96-11.08%

XLOXilio Therapeutics, Inc.

XLOXilio Therapeutics, Inc.$7.79-1.64%

ALGSAligos Therapeutics, Inc.

ALGSAligos Therapeutics, Inc.$5.97-5.09%

ATNMActinium Pharmaceuticals, Inc.

ATNMActinium Pharmaceuticals, Inc.$1.17-1.68%

FGENFibroGen, Inc.

FGENFibroGen, Inc.$9.07-1.63%

BRNSBarinthus Biotherapeutics plc

BRNSBarinthus Biotherapeutics plc$0.60-1.66%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.46+0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.86+0.02%

INTCIntel

INTCIntel$94.75+0.12%

FFord Motor Company

FFord Motor Company$12.24-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$53.08-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.93-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$15.53-0.15%

Questions About OKUR

What is the current price of OnKure Therapeutics?

OnKure Therapeutics is trading at $5.11 per share.

What is the 52-week range for OnKure Therapeutics?

Over the past 52 weeks, OnKure Therapeutics has traded between $1.70 and $5.36.

How much debt does OnKure Therapeutics have?

As of the most recent reporting period, OnKure Therapeutics reported total debt of $549,000.

How much cash does OnKure Therapeutics have on hand?

OnKure Therapeutics reported $59.05M in cash and cash equivalents in its most recent financial results.

What is OnKure Therapeutics’s dividend yield?

OnKure Therapeutics does not currently have a dividend yield.

OnKure Therapeutics

OnKure Therapeutics Financials at a Glance

OKUR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About OnKure Therapeutics

OKUR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

OnKure Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OKUR

What is the current price of OnKure Therapeutics?

What is the 52-week range for OnKure Therapeutics?

How much debt does OnKure Therapeutics have?

How much cash does OnKure Therapeutics have on hand?

What is OnKure Therapeutics’s dividend yield?

Premium Investing Services